ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
13 hedge funds and large institutions have $15.1M invested in Avenue Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$788K | |
| 2 | +$292K | |
| 3 | +$189K | |
| 4 |
6CM
683 Capital Management
New York
|
+$131K |
| 5 |
Renaissance Technologies
New York
|
+$121K |
Top Sellers
| 1 | -$195K | |
| 2 | -$87K | |
| 3 | -$76K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$19K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |